PortfoliosLab logoPortfoliosLab logo
BCOG.L vs. BIGT.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BCOG.L vs. BIGT.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in L&G All Commodities UCITS ETF (BCOG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BCOG.L achieves a 19.93% return, which is significantly higher than BIGT.L's 7.76% return.


BCOG.L

1D
-0.83%
1M
1.09%
6M
14.90%
YTD
19.93%
1Y
28.94%
3Y*
11.35%
5Y*
10.86%
10Y*

BIGT.L

1D
-1.28%
1M
7.11%
6M
6.84%
YTD
7.76%
1Y
33.20%
3Y*
9.77%
5Y*
3.20%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BCOG.L vs. BIGT.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
BCOG.L
L&G All Commodities UCITS ETF
19.93%8.16%6.13%-12.32%29.36%29.04%-6.24%1.82%-1.43%
BIGT.L
L&G Pharma Breakthrough UCITS ETF
7.76%27.03%-3.16%-14.88%2.68%-2.30%23.89%9.47%-28.12%

Correlation

The correlation between BCOG.L and BIGT.L is -0.20, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.20

Correlation (3Y)
Calculated over the trailing 3-year period

-0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.02

Correlation (All Time)
Calculated using the full available price history since Jan 18, 2018

0.12

The correlation between BCOG.L and BIGT.L shifts across timeframes, from -0.20 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BCOG.L vs. BIGT.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BCOG.L
BCOG.L Risk / Return Rank: 5454
Overall Rank
BCOG.L Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
BCOG.L Sortino Ratio Rank: 5151
Sortino Ratio Rank
BCOG.L Omega Ratio Rank: 5757
Omega Ratio Rank
BCOG.L Calmar Ratio Rank: 5353
Calmar Ratio Rank
BCOG.L Martin Ratio Rank: 4949
Martin Ratio Rank

BIGT.L
BIGT.L Risk / Return Rank: 6767
Overall Rank
BIGT.L Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
BIGT.L Sortino Ratio Rank: 6565
Sortino Ratio Rank
BIGT.L Omega Ratio Rank: 5959
Omega Ratio Rank
BIGT.L Calmar Ratio Rank: 7979
Calmar Ratio Rank
BIGT.L Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BCOG.L vs. BIGT.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G All Commodities UCITS ETF (BCOG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BCOG.LBIGT.LDifference
Sharpe ratioReturn per unit of total volatility

-0.14

Sortino ratioReturn per unit of downside risk

-0.35

Omega ratioGain probability vs. loss probability

1.29

1.29

-0.01

Calmar ratioReturn relative to maximum drawdown

2.17

3.33

-1.16

Martin ratioReturn relative to average drawdown

6.72

9.47

-2.75

BCOG.L vs. BIGT.L - Sharpe Ratio Comparison

The current BCOG.L Sharpe Ratio is 1.59, which is comparable to the BIGT.L Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of BCOG.L and BIGT.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BCOG.L vs. BIGT.L - Drawdown Comparison

The maximum BCOG.L drawdown since its inception was -40.03%, which is greater than BIGT.L's maximum drawdown of -36.84%. Use the drawdown chart below to compare losses from any high point for BCOG.L and BIGT.L.


Loading charts...

Drawdown Indicators


BCOG.LBIGT.LDifference

Max Drawdown

Largest peak-to-trough decline

-40.03%

-36.84%

-3.19%

Max Drawdown (1Y)

Largest decline over 1 year

-13.29%

-9.93%

-3.36%

Max Drawdown (3Y)

Largest decline over 3 years

-26.54%

-28.44%

+1.90%

Max Drawdown (5Y)

Largest decline over 5 years

-27.76%

-30.23%

+2.47%

Current Drawdown

Current decline from peak

-8.99%

-6.64%

-2.35%

Average Drawdown

Average peak-to-trough decline

-18.97%

-17.21%

-1.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.29%

3.50%

+0.79%

Volatility

BCOG.L vs. BIGT.L - Volatility Comparison

The current volatility for L&G All Commodities UCITS ETF (BCOG.L) is 4.56%, while L&G Pharma Breakthrough UCITS ETF (BIGT.L) has a volatility of 6.49%. This indicates that BCOG.L experiences smaller price fluctuations and is considered to be less risky than BIGT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BCOG.LBIGT.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.56%

6.49%

-1.93%

Volatility (6M)

Calculated over the trailing 6-month period

16.06%

14.29%

+1.77%

Volatility (1Y)

Calculated over the trailing 1-year period

18.09%

19.03%

-0.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.54%

21.46%

+0.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.84%

23.23%

-3.39%

BCOG.L vs. BIGT.L - Expense Ratio Comparison

BCOG.L has a 0.15% expense ratio, which is lower than BIGT.L's 0.49% expense ratio.


Dividends

BCOG.L vs. BIGT.L - Dividend Comparison

Neither BCOG.L nor BIGT.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


BCOG.L and BIGT.L have a correlation of -0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BCOG.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BCOG.L is cheaper with a 0.15% expense ratio, compared with 0.49% for BIGT.L.

BCOG.L is categorized as Commodities, while BIGT.L is Health & Biotech Equities. BCOG.L tracks Bloomberg Commodity, while BIGT.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.15% for BCOG.L and 0.49% for BIGT.L.

Portfolio Optimizer

Find the right allocation for BCOG.L and BIGT.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer